Patients with underlying hematologic or oncologic disease require management of
menstrual bleeding, but also deserve a comprehensive evaluation and counseling …

Background Adolescents and young adult (AYA) women with cancer are at risk of heavy
menstrual bleeding (HMB) due to thrombocytopenia, coagulopathy, and/or disruption of the …

Background Current guidelines recommend the use of combined hormonal contraceptive
pills for menstrual suppression in pediatric blood and marrow transplant (BMT) recipients but …

Abstract Study Objective To assess the frequency, severity, and inpatient management of
girls admitted with heavy menstrual bleeding and iron deficiency anemia at US children's …

Objectives To describe practice patterns of an integrated complex family planning-pediatric
hematology oncology clinic for patients with blood disorders Study design We …

PURPOSE Adolescent and young adult female patients receiving myelosuppressive cancer
treatments are at risk of abnormal uterine bleeding (AUB). The frequency with which patients …

Cancer in women ages 15 to 19 years is relatively rare, but when it occurs, menstruation can
result in clinically significant complications. 1 During the care of hematologic malignancies …

Bleeding disorders constitute an important etiology of heavy menstrual bleeding in
adolescents that require detailed history taking, careful planning of the laboratory …

Importance Heavy menstrual bleeding is a common cause of anemia and reduced quality of
life in adolescents. There is a higher prevalence of bleeding disorders in girls with heavy …

An essential component of a cancer patient's comprehensive care is addressing potential
threats to his or her reproductive health. Providers should discuss the risk of infertility with …